MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-28-2026
Novartis AG EV/EBITDA Ratio 2011-2026 | NVS
Annual EV/EBITDA Ratio Novartis AG
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 16.5 | 14 | 15.8 | 13.1 | 14.4 | 11.9 | 12.8 | 13.9 | 11.8 | 9.86 | 7.89 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.5 | 7.89 | 12.9 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
-6.39 | $ 20.32 | -1.86 % | $ 2.56 B |  USA |
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.82 | -2.7 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
-8.03 | $ 165.39 | -0.6 % | $ 8.23 B | USA |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
9.24 | $ 3.65 | -4.58 % | $ 1.09 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Corvus Pharmaceuticals
CRVS
|
0.244 | $ 17.24 | -3.63 % | $ 828 M | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
-2.14 | $ 25.62 | -4.62 % | $ 686 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | Canada |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Codexis
CDXS
|
-100 | $ 0.99 | -2.59 % | $ 72.7 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-8.96 | $ 3.18 | -4.94 % | $ 1.14 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-5.08 | $ 28.47 | -2.5 % | $ 1.65 B | USA |
 |
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
7.12 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-115 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-1.37 | $ 3.64 | -4.21 % | $ 116 M | France |
 |
Alector
ALEC
|
-44.8 | $ 2.13 | -3.39 % | $ 219 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-1.66 | $ 4.15 | -0.24 % | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
2.8 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-1.96 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 24.06 | 0.75 % | $ 2.94 B | USA |
 |
Amarin Corporation plc
AMRN
|
123 | $ 13.95 | 0.14 % | $ 5.79 B |  Irlanda |
 |
AbbVie
ABBV
|
11.9 | $ 231.93 | -0.98 % | $ 410 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
977 | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |